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Abstract
Stress negatively affects cognitive performance. Probiotics remediate somatic and behavioral stress responses,
hypothetically by acting on the gut microbiota. Here, in exploratory analyses, we assessed gut microbial alterations
after 28-days supplementation of multi-strain probiotics (EcologicBarrier consisting of Lactobacilli, Lactococci, and
Bifidobacteria in healthy, female subjects (probiotics group n= 27, placebo group n= 29). In an identical pre-session
and post-session, subjects performed a working memory task before and after an acute stress intervention. Global gut
microbial beta diversity changed over time, but we were not able to detect differences between intervention groups.
At the taxonomic level, Time by Intervention interactions were not significant after multiple comparison correction;
the relative abundance of eight genera in the probiotics group was higher (uncorrected) relative to the placebo group:
Butyricimonas, Parabacteroides, Alistipes, Christensenellaceae_R-7_group, Family_XIII_AD3011_group,
Ruminococcaceae_UCG-003, Ruminococcaceae_UCG-005, and Ruminococcaceae_UCG-010. In a second analysis step,
association analyses were done only within this selection of microbial genera, revealing the probiotics-induced change
in genus Ruminococcaceae_UCG-003 was significantly associated with probiotics’ effect on stress-induced working
memory changes (rspearman(27)= 0.565; pFDR= 0.014) in the probiotics group only and independent of potential
confounders (i.e., age, BMI, and baseline dietary fiber intake). That is subjects with a higher increase in
Ruminococcaceae_UCG-003 abundance after probiotics were also more protected from negative effects of stress on
working memory after probiotic supplementation. The bacterial taxa showing an increase in relative abundance in the
probiotics group are plant fiber degrading bacteria and produce short-chain fatty acids that are known for their
beneficial effect on gut and brain health, e.g., maintaining intestinal-barrier and blood–brain-barrier integrity. This
study shows that gut microbial alterations, modulated through probiotics use, are related to improved cognitive
performance in acute stress circumstances.
Introduction
Stress, regardless of its origin (physical, mental, or
social), activates the hypothalamic-pituitary-adrenal
(HPA) axis1; a neuroendocrine system that controls the
body’s stress response. Stress-induced glucocorticoids
released by the adrenal cortex impact many tissues in the
body, including the brain where it affects cognitive per-
formance (e.g., working memory2). Moreover, stress plays
an important role in the neurobiology of mood disorders,
including depressive and bipolar disorders3. The systemic
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effects of stress include mediation by the gut-brain axis
(GBA) (for a review see Foster et al.4). This axis refers to
the bidirectional communication between the gastro-
intestinal tract and the central nervous system, which is
not only mediated by endocrine signaling including hor-
mones and other neuro-active metabolites, but also by the
vagus nerve and by the immune system5. The gut bacteria
(gut microbiota) modify the functioning of the GBA6,
making it a key player in behavior and stress reactivity4. A
strong illustration of the role of the microbiota in the
GBA and its effect on (healthy) behavior are the results of
the experiments carried out in germ-free mice (i.e., mice
reared in a germ-free environment preventing coloniza-
tion of the intestinal tract) or animals subjected to wash
out of their bacterial community by antibiotics. These
animal models clearly show cognitive impairments, mul-
tiple behavioral disturbances such as altered anxiety
responses, learning problems, and exaggerated stress
reactivity7,8. Sudo et al.9 observed altered HPA axis
functioning in germ-free mice, i.e., amplified corticoster-
one response to stress induced by physical restraint,
compared with control mice. The gut microbiota is a
promising target for protection against negative effects of
stress, as it is modifiable through e.g., diet or probiotics4.
Probiotics are defined as “live, micro-organisms, which
induces a health benefit to the host when administered in
adequate amounts”10. Use of probiotics can be advised in
case of irregularities in digestion and or stool composition
such as diarrhea, aiming to re-establish more diverse gut
microbiota abundance and reduce gastrointestinal com-
plaints11. With the increasing awareness of the impor-
tance of the link between the microbiota-GBA in mood
and stress-related symptoms, the potential of probiotics in
protecting and or restoring these symptoms has been
explored12,13.
In the above-mentioned experiment in germ-free mice,
Sudo et al.9 showed that the amplified corticosterone
response to stress was normalized after supplementation
with the bacterial strain Bifidobacterium infantis. Other
animal studies showed that probiotics reduce anxious
behaviors in response to physical stressors: i.e., less
defensive probe burying after receiving shocks when sup-
plemented with Lactobacillus helveticus R0052 and Bifi-
dobacterium longum R0175 for two-weeks14; more time
spent in an open field after hypothermia when supple-
mented with L. rhamnosus for 29 days15; and reduced
immobilization time in a forced swim test after 5-week
supplementation of the same multi-species probiotics mix
as used in this study16. In human randomized placebo-
controlled trials (RCTs), probiotics have also demon-
strated beneficial effects on physical and/or psychological
complaints in response to experimental acute stress
paradigms or daily life stress. For example, subjects
showed reduced depressive symptoms after 30-days of
supplementation of the same 2-strain probiotic product
effective in the animal study mentioned above14. Adults
experiencing moderate stress symptoms on the Perceived
Stress Scale (PSS-10) at baseline reported fewer of these
symptoms after 8-weeks of use of Lactobaccilus Plan-
tarum DR7 strain17 or after 12-weeks of use of the
P8 strain of the same species18. Reduced abdominal
complaints during exam stress were observed using Lac-
tobacillus casei for 8 weeks19. Similarly, eight-week sup-
plementation of the Lactobacillus casei strains Shirota YIT
9029 relieved abdominal pain and exam stress20. After an
acute stress paradigm, i.e., the socially evaluated cold
pressor test (SECPT), fewer self-reported anxiety symp-
toms were observed after 4 weeks of Bifidobacterium
longum 1714 use than after placebo21. In contrast, in two
other RTCs in healthy volunteers, no alterations in stress-
related measures were observed after two weeks of sup-
plementation of Lactobacilli, Bifidobacteria, and Strepto-
cocci strains22 or after eight-week Lactobacillus rhamnosus
supplementation23. Thus, although probiotics have been
shown to affect human stress-related measures in some
studies, the effects are not always replicated and more
research is needed to understand whether and which gut
microbial changes underly these cognitive effects.
The negative effects of (acute) stress on cognitive
functioning have been rarely assessed in a probiotics trial.
The double-blind RCT reporting fewer stress symptoms
after 8-weeks Lactobaccilus Plantarum DR7 strain expo-
sure also observed probiotic-induced improvements in
emotion recognition speed and verbal memory speed17.
Allen et al. observed fewer stress (SECPT) induced errors
on a visuospatial memory task after 4 weeks of Bifido-
bacterium longum 171421. Moreover, Papalini et al.24
assessed the effect of 4-week multi-strain probiotics
supplementation on neurocognitive functioning in a
double-blind RTC in healthy female volunteers. Probiotics
protected against working memory detriments caused by
an acute stress paradigm. That is, the probiotics group
performed better after (versus before) the SECPT on a
digit span backward test compared with the placebo
group. Furthermore, this protecting effect of probiotics on
the working-memory decline after stress was associated
with changes in prefrontal cortex fMRI signal during
cognitive control. From the above studies, it is, however,
unclear how probiotics could exert their effect on central
neural processing and cognitive performance. One path-
way underlying the effects of probiotics on the GBA could
be a specific alteration in microbial composition. Mea-
suring probiotics-induced gut microbial alterations can
help identify which bacteria mediate the protecting effects
of probiotics on mental health and cognitive performance
and can provide mechanistic insights into e.g., metabolite
production and other microbial functions25. Yet, almost
none of the above-mentioned studies report the effect of
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probiotics supplementation on gut microbial profiling.
Kato-Kataoka et al.20 did observe higher alpha gut
microbial diversity in the probiotics group in addition to
lowered stress symptoms. However, the authors did not
report an association between these measures of stress
and microbiota. Another microbiota-GBA study assessed
the effects of a Lactobacilli and Lactococci probiotics
mixture on the gut microbial composition and emotional
memory of healthy volunteers and found that increased
memory was associated with decreased abundance of nine
genera26. However, these results were not observed in the
context of stress-reactivity. Here, we aimed to assess how
probiotics can buffer against the detrimental effects of
stress on cognition by investigating the link with the
probiotics-induced changes in the gut microbiota. For
this, we used the data of the Papalini et al.24 study, where
28-days multi-species probiotics versus placebo supple-
mentation were shown to improve working memory (i.e.,
digit span backward) performance after an acute stressor
(i.e., the socially evaluated cold pressor test) in healthy
female volunteers. We extend this work by assessing, first,
whether this probiotics product alters gut microbial
composition versus placebo and, second, whether this
probiotics’ effect on gut microbial composition relates to




Healthy female subjects, aged between 18 and 40 years
old were included (see Supplementary Materials for fur-
ther inclusion criteria). A total of 61 healthy subjects were
tested, of which one subject was excluded from the study
due to high scores on the Beck Depression Inventory
questionnaire (BDI), potentially indicating depression. For
two subjects the pre-intervention fecal material was
lacking, resulting in 58 subjects for the gut microbiota
analysis (n= 27 in the probiotics group, n= 31 in the
placebo group) (see Supplementary Fig. 1). Two other
subjects scored poorly on the behavioral tasks and were
excluded, resulting in a total sample—including both
microbiota and neuro-cognitive data—of 56 subjects
(probiotics group: n= 27, mean age= 21.8, SEM= 0.5,
mean BMI= 21.9, SEM= 0.32; placebo group: n= 29,
mean age= 22.4, SEM= 0.53, mean BMI= 21.7, SEM=
0.30). These exclusions although not pre-established were
made to ensure a sample representative of the healthy
population with reliable task performance. The groups did
not differ in age, BMI, and neither in baseline dietary
intake as reported in the Food Frequency Questionnaire
Dutch Healthy Diet (FFQ-DHD)27, see Supplementary
Table 1. The study was conducted following the
Declaration of Helsinki with human subjects and the
complete procedure was approved by the local Ethics
Committee (CMO Arnhem-Nijmegen, NL55406.091.15)
and registered at the Dutch trial register (protocol num-
ber: NTR5845). Written informed consent was obtained
from each participant. The current analysis on gut
microbial composition is an exploratory analysis for
which no sample size was determined. The sample size is
based on the sample needed for the effect of probiotics on
neuro-cognitive measures as reported in seeing Papalini
et al.24 which was n= 30 per intervention group. For an
exhaustive description of the methods in this study, see
Papalini et al.24, of which this study is an extension.
Procedure Subjects were tested on two days: the first
day (baseline), before the intervention started, and the
second day after 28 days (four weeks) of probiotics or
placebo administration. The identical test sessions
included cognitive testing in and outside the MRI
scanner, an acute stress intervention, and fecal material
collection before starting and after the last day of the
intervention (see Fig. 1).
Relevant to the current analyses, the working memory
task (digit span forward and backward) was performed
before and after the SECPT. The SECPT is an established
Fig. 1 Overview of the testing sessions. Each participant was tested twice, before and after 4 weeks of supplementation with probiotics/placebo.
The procedure of the two sessions was the same (i.e., subjects performed the same tests in the same order). Tx: x minutes since the start of the test
session. SECPT: socially evaluated cold pressor test.
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stress-inducing paradigm consisting of both a physical
and a social stressor28. Also in this experiment, the
SECPT increased subjective feelings of stress measured
with Visual Analogue Scales (VAS) and increased phy-
siological measures, i.e., heart rate, blood pressure, and
cortisol levels, in our subjects (see Fig. 4 in Papalini
et al.24). During the digit span task, subjects listen to a
series of numbers and are instructed to repeat each series
correctly (digit span forward) or repeat it backward (digit
span backward). Following a correct response, increas-
ingly longer sequences are presented to the participant.
Different series of numbers are used on each occasion
(before and after stress on the first and second test day) to
avoid long-term memory effects. In the SECPT28, subjects
were instructed to hold their hand in a bucket of ice water
(0 – 3 °C) for as long as possible (limited to 3 min) under
the surveillance of a video camera and an unfamiliar,
disesteem expressing researcher. After the SECPT, the
digit span was re-tested, thereby enabling assessment of
stress on working memory performance. As in our pre-
vious work24, we only focus on the digit span backward,
given that SECPT specifically influenced this type of
working memory modulation instead of simply working
memory maintenance that is needed in the digit span
forward29. Throughout the test session, VAS was used to
assess well-being (5 times), heart rate and blood pressure
were measured (7 times), and saliva samples (5 times)
were obtained. Three fMRI paradigms measuring differ-
ent aspects of emotion and cognition were performed
while scanning. Once per test session, we further eval-
uated mood, emotional state, sensitivity, and diet. The
total test session lasted almost 3 h. The effects of the
probiotics versus placebo intervention on these measures
have already been reported in Papalini et al.24.
Intervention The used probiotics product Ecolo-
gic®Barrier (Winclove, The Netherlands) consists of the
following bacterial strains: Bifidobacterium bifidum W23,
Bifidobacterium lactis W51, Bifidobacterium lactis W52,
Lactobacillus acidophilus W37, Lactobacillus brevis W63,
Lactobacillus casei W56, Lactobacillus salivarius W24,
Lactococcus lactis W19, and Lactococcus lactis W58. The
total cell count was 2.5 × 109 colony forming units (cfu)
per gram, and subjects consumed 2 g per day i.e., 5 × 109
cfu per day. More information on the product in the
Supplementary Materials.
Microbiome sample processing Fecal sample collection
Fecal samples were collected by the subjects at home
using a validated protocol by OMNIgene•GUT kit
(DNAGenotek, Ottawa, CA). The material was aliquoted
into 1.5 ml Eppendorf tubes and stored in −80 °C until
further laboratory processing. Bacterial DNA isolation
and sequencing For bacterial DNA extraction, 50 mg of
feces was separated from 200 µl of OMNIgene•GUT kit
buffer by centrifugation at 1400 rcf at 16 °C for 5 min.
Microbial DNA was isolated from fecal pellets using the
Maxwell® 16 Instrument (Promega, Leiden, The Neth-
erlands) as described previously30. DNA purification was
performed with a customized kit (AS1220; Promega)
using 250 μl of the final supernatant pool. The V4 region
of 16S ribosomal RNA (rRNA) gene was amplified in
duplicate PCR reactions for each sample in a total reac-
tion volume of 50 μl. The V4 region was targeted by using
previously reported primers for this region: 515F (5′
GTGYCAGCMGCCGCGGTAA)–806R (5′ GGACTACN
VGGGTWTCTAAT)30. We included a PCR negative
sample to assess the contamination introduced during this
step. The purified samples were used to prepare libraries
for the Illumina HiSeq PE300 (paired-end, 300 bp)
sequencing platform (GATC Biotech AG, Konstanz,
Germany), with final loading concentrations of 200 ng/µl.
For more information on the wet lab procedure, see
refs. 31,32
Data analyses bioinformatics
Using the NG-Tax 16S rRNA pipeline33, taxonomic
information was assigned. Briefly, the pipeline can be
defined by three core elements: (i) barcode-primer filtering,
(ii) operational taxonomic unit (OTU) picking, and (iii)
taxonomic assignment using the SILVA reference database
(version 128). Two filtering steps were applied to the
output file (BIOM-file) of NG-Tax. First, a genus was fil-
tered based on a 10% prevalence cutoff. Second, a sample
with less than 10% of genera was removed (see ref. 31). To
avoid bias in assessing the effects of the intervention, fil-
tering was done on the pre-intervention session. In total,
9,819,945 high-quality sequences were obtained from all
samples after NG-Tax pipeline. These sequences were
represented by 1043 OTUs and 175 genera. After the fil-
tering steps, we obtained 9,681,326 sequences represented
by 898 OTUs and 86 genera. No samples were removed
during these steps.
Statistical analyses
The analyses followed a two-step approach (see Fig. 2).
Step 1: assessing effects of probiotics on gut microbiota
(community and composition analysis) and step 2: asso-
ciation between effects of probiotics on gut microbiota and
neurocognitive measures. Step 1 served as a selection cri-
terium for the association analysis in step 2. Overall, tests
are performed two-sided and corrected for multiple com-
parisons. The biom file used for these analyses is available
at 10.6084/m9.figshare.13614494. The raw sequences,
QIIME, and R code used to analyze gut microbial com-
position are available upon request.
Community analyses Alpha-diversity: Alpha-diversity was
estimated in three ways using QIIME 1.9.134: (i) a richness
measure counting observed OTUs, (ii) Shannon Index
taking into account also abundance of the counted OTU’s
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and (iii) Faith’s Phylogenetic Diversity, taking into account
the evolutionary phylogenetic structure. After normality was
verified, repeated measures ANOVAs were performed on
between-subjects factor Intervention (Placebo, Probiotics)
and within-subjects factor Time (Pre, Post), assessing Time
(Pre, Post) * Intervention (Placebo, Probiotics), as well as a
priori, hypothesized simple effects. The results are presented
as differences (delta) between the pre-intervention and post-
intervention (after 4 weeks), symbolized by Δ.
Beta-diversity: The beta-diversity was calculated based on
weighted UniFrac35. Weighted UniFrac is a distance metric;
explaining differences in the relative abundances between
microbial communities based on their evolutionary phylo-
genetic structure. Permutation testing was performed in R
(version 3.6.3) using the function vegan::adonis36, testing for
interaction effects of Time (Pre, Post) * Intervention (Pla-
cebo, Probiotics), as well as a priori hypothesized simple
effects in the weighted UniFrac distance metric, accounting
for repeated measures by using the ‘strata’ argument when
testing effects of Time. To visualize intervention effect on
beta-diversity Constrained Analysis of Principal Coordinates
(CAP) was performed using the R function vegan::capscale37.
Composition analyses
Taxonomic Differences: The differences in microbial
communities between pre-intervention and post-
intervention groups were determined at the phylum and
genus levels, based on the bacterial relative abundance
profiles. Significant differences in relative abundance dif-
ference values, post-intervention versus pre-intervention
(symbolized by Δ), between probiotics and placebo groups
were identified by non-parametric Mann–Whitney U tests.
Critically, this test on the genera altered by the probiotics
intervention was used as a selection criterium for step 2:
association analyses with neuro-cognitive measures,
thereby restricting the number of tests for this second
research question. Of these, genera with relative abundance
levels differing between groups at baseline were not further
analyzed (see Fig. 2).
Association analyses between intervention-induced
changes in the gut microbiota and neuro-cognition: As
reported in Papalini et al., after one-month supple-
mentation of probiotics, the scores of the digit span
backward improved after the stress-inducing SECPT
paradigm, while this effect was not observed in the
Fig. 2 Analysis flow chart. In a first step, community dynamics were compared between intervention (post-intervention versus pre-intervention)
groups, and the composition of the two intervention groups was compared at the genus level. Secondly, the results of step 1 were used as a
selection criterium to associate gut microbial candidates with neuro-cognitive measures.
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placebo group. The association analysis focused pri-
marily on this result: assessing whether the protective
effect of probiotics on stress-induced working memory
changes is explained by changes in gut microbial com-
position due to probiotics use. To this aim, firstly, only
genera altered due to probiotics exposure (i.e., post–pre
increase or decrease (Δ) in relative abundance after
probiotics versus placebo) were selected for the down-
stream analysis.
Using correlation analyses, these genera were screened for
a relation with the effect of probiotics (post–pre) on
working memory (digit span backward, DS) after versus
before stress, i.e., (DSafter–DSbefore stress)post-intervention−
(DSafter–DSbefore stress)pre-intervention (see Fig. 2).
Due to the overall skewness of the microbiota data, two-
tailed non-parametric Spearman correlations were per-
formed. Only results passing False Discovery Rate (FDR)
correction were analyzed in a multiple regression analysis.
Here, the effect of potential confounders was assessed by
adding BMI, age, and baseline fiber intake (measured by
the DHD) in a linear regression model. The efficacy of
probiotics may vary with age and BMI due to metabolic
and gastro-intestinal differences38,39. Although no chan-
ges in the dietary patterns were observed over the course
of the intervention, baseline fiber intake may still be a
modulator of the effect of probiotics as these serve as a
nutrient source for the microbiota40.
The specificity of the association between the effect of
probiotics on gut microbial abundance and stress-related
working memory was assessed by comparing the
regression slopes between the probiotics and placebo
groups. This was done by creating a dummy variable that
divided the intervention groups and subsequently
creating an interaction term between this dummy vari-
able and the genus variable. This interaction term was
then added in a new regression, assessing whether the
relative abundance of the selected genus differentially
affects stress-induced working memory changes in the
two intervention groups. For results on the secondary
analyses that were performed on fMRI signal and phy-
siological stress measures, see Supplementary Methods.
The statistical analyses were performed using IBM SPSS
statistics (package version 23).
Results
Gut microbiota composition before intervention
The intestinal microbiota of the 58 subjects before the
intervention (Pre) was typical for healthy individuals;
dominated largely by the phyla Firmicutes (68.0%) and
Bacteroidetes (19.5%), accounting for up to 87.5% of the
intestinal microbial communities. Other observed phyla
were Actinobacteria (8.7%), Proteobacteria (1.5%), Ver-
rucomicrobia (1.4%), Euryarchaeota (0.4%), Tenericutes
(0.29%), and Cyanobacteria (0.25%).
Effect of probiotics on gut microbiota community
The three alpha diversity measures did not show sig-
nificant interaction effects between Time and Interven-
tion, or simple effects in the probiotics and placebo
groups, all p > 0.05 (Supplementary Fig. 2). Beta-diversity
at the operational taxonomic unit (OTU) level did not
show a significant interaction between Time (pre, post)
and Intervention (placebo, probiotics) (p= 0.244, r2=
0.003). However, there was a main effect of Time across
Interventions (p= 0.011, r2= 0.01). That is, the post-
intervention samples were more similar among each other
compared with the pre-intervention samples. Constrained
analysis of principle coordinates (CAP) ordination
method was used to visualize the main effect of Time
(accounting for R2= 1% variability in the dataset) (Fig. 3).
Exploratory post-hoc analyses suggest that the Time effect
is more likely driven by changes within the probiotics
group (post versus pre-4-week of intervention (p= 0.008),
rather than the placebo group (p= 0.21) (Supplementary
Table 2). It’s critical to note that the absence of Time by
Intervention interaction indicates that that probiotic and
placebo intervention affected the beta diversity in a
similar fashion as shown in Fig. 3.
Effect of probiotics on gut microbiota composition: At the
phylum level, we did not find significant differences
between a post–pre increase or decrease (Δ) in relative
abundance after probiotics versus placebo; Supplementary
Table 3). At the genus level, we identified nine genera
with FDR-uncorrected significant changes in relative
abundance in the probiotics group (post-intervention
versus pre-intervention). One of these nine (Para-
bacteroides) was different at baseline between the pro-
biotics and placebo group and was therefore not taken
into consideration for further analyses (Table 1, Supple-
mentary Fig. 3A–H). Another classification (Lachnospir-
aceae_g__) is in fact a sequence for which no classification
Fig. 3 Beta diversity. Weighted Unifrac dissimilarity matrix plotted
using Canonical Analysis of Principal Coordinates (CAP) ordination for
all groups and timepoints.
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to an OTU could be made with sufficient confidence,
resulting in a grouping of OTU’s with insufficient con-
fidence. This grouping of genera within the Lachnospir-
aceae family was also not taken forward for further
analysis.
Association between gut microbiota composition and
neurocognitive measures: Seven genera were used to assess a
correlation with the protective effect of probiotics on
working memory (digit span backward scores) after stress24.
Of these, the post-change versus pre-change in the relative
abundance of genus Ruminococcaceae_UCG-003 was
significantly correlated with the change in the effect
of stress on working memory in the probiotics group
(rspearman(27)= 0.565; pFDR= 0.014) (see Fig. 4). In the
probiotics group, a larger increase (post-intervention
versus pre-intervention) in the relative abundance of
Ruminococcaceae_UCG-003 was associated with higher
(post-intervention versus pre-intervention) stress-related
working memory performance (digit span backward,
post-SECPT versus pre-SECPT). Linear regression was
subsequently used to assess potential confounders in
the relationship between probiotics-induced changes
in working memory performance after stress and
Ruminococcaceae_UCG-003 (Δ scores). Age, BMI at base-
line, as well as baseline dietary fiber intake were identified as
potentially modulating the effect of probiotics and its
relation with neurocognitive measures. None of these
confounders had a significant effect in the model (model
without potential confounders; Adjusted R2= 0.14,
Standardized Beta Ruminococcaceae_UCG-003= 0.45,
p= 0.018, a model with potential confounders; Standar-
dized Beta Ruminococcaceae_UCG-003= 0.50, p= 0.022,
potential confounders: Age: Standardized Beta=−0.117,
p= 0.565, BMI: Standardized Beta=−0.133, p= 0.661,
baseline reported fiber intake: Standardized Beta= 0.170,
p= 0.814). Dietary intake (DHD-FFQ) scores were not
affected by the intervention; all p > 0.05 (for scores see
Supplementary Table 1). The association between
probiotics-induced changes in working memory perfor-
mance after stress and Ruminococcaceae_UCG-003
(Δ scores) was not significant in the placebo group
(B=−0.179, p= 0.296). Indeed, the association was
significantly greater for the probiotics’ than for the placebo
group: the regression coefficients for the effect of
Ruminococcaceae_UCG-003 on stress-induced working
memory changes in the probiotics and placebo groups were
significantly different (Slope comparison interaction term:
Beta=−0.614, p= 0.009).
For reference, plots on the non-significant relation
between the other seven genera and digit span scores are
provided in Supplementary Fig. 4. The secondary analysis
on the neural signal during cognitive control and
physiological measures did not give significant associa-
tions with change in Ruminococcaceae_UCG-003 abun-
dance, see Supplementary Results.
Discussion
Here, we show that the effects of multi-strain probiotics
on stress-related cognitive performance are associated
with changes in the gut microbiota composition. This
association was exclusive to the probiotics group and
independent of the potential confounders' age, BMI, and
baseline dietary fiber intake.




ΔProbiotics mean (range)a ΔPlacebo
mean rank
ΔPlacebo mean (range)a P-valueb
Butyricimonas 33.78 0.04 (−0.26–0.45) 25.77 −0.02 (−0.29–0.01) 0.014
Parabacteroidesc 34.78 −0.003 (−0.83–0.69) 24.90 −0.22 (−1.87–2.51) 0.026
Alistipes 34.20 −0.05 (−4.32–1.82) 25.40 −0.18 (−3.06–3.25) 0.048
Christensenellaceae_R-7_group 36.11 0.5 (−1.34–3.14) 23.74 −0.72 (−8.10–3.33) 0.005
Family_XIII_AD3011_group 34.11 0.09 (0.00–0.54) 25.48 0.03 (−0.14–0.52) 0.032
f_Lachnospiraceae;g_ 23.70 −1.09 (−10.67–10.93) 34.55 1.17 (−9.95–9.21) 0.015
Ruminococcaceae_UCG-003 34.30 0.07 (−0.27–0.52) 25.32 −0.04 (−0.68–0.34) 0.038
Ruminococcaceae_UCG-005 34.70 0.29 (−1.42–1.82) 24.97 −0.27 (−5.69–1.41) 0.028
Ruminococcaceae_UCG-010 35.04 0.09 (−0.29–0.95) 24.68 −0.06 (−0.83–0.98) 0.010
aMean and range of the difference scores are given to provide descriptive statistics; these values have no relation with the p-values.
bP-values (uncorrected) are given for non-parametric Mann–Whitney U test assessing the differences in rank order. These non-parametric rank tests were performed
due to the overall skewness of the microbiota data including many zero values. A cut-off was placed including maximally 90% zero values (see the “Methods” section
for more details).
cDifferent at baseline.
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Healthy, female subjects took multi-strain probiotics or
placebo for 28 days and donated fecal material at baseline
and after the intervention period. In an identical pre-
intervention and post-intervention session, subjects per-
formed a working memory task before and after an acute
stress manipulation. Gut microbial beta diversity did not
show a significant interaction between Intervention and
Time but changed over time across intervention groups. In
terms of gut microbial composition, we observed increased
relative abundance of the genera Butyricimonas, Alistipes,
Christensenellaceae_R-7_group, Family_XIII_AD3011_group,
Ruminococcaceae_UCG-003, Ruminococcaceae_UCG-005,
and Ruminococcaceae_UCG-010 in the probiotics versus the
placebo group, (uncorrected for multiple comparisons).
These genera showing an uncorrected higher relative abun-
dance are part of known abundant taxa observed in the
healthy human gut41,42. Of these genera selected for
a second analysis step, only Ruminococcaceae_UCG-003 was
significantly associated with the effect of probiotics
on working memory performance after stress, where
subjects with a larger probiotics-induced increase in
Ruminococcaceae_UCG-003 abundance also showed a
greater protective effect of probiotics on stress-induced
working memory changes.
It is the first time that the effects of these multi-strain
probiotics on gut microbiota composition are tested in
humans. Our results show uncorrected probiotics-induced
changes in the relative abundance of several genera. These
are associated with gastrointestinal health and lifestyle
choices; Ruminococcaceae_UCG-003, and uncorrected
also Butyricimonas, Family_XIII_AD3011_group, f_Lach-
nospiraceae, were found to be less abundant in healthy
men reporting to smoke and drink alcohol43. Genus
Alistipes, Ruminococcaceae_UCG-005, and Christense-
nellaceae R-7 group have been previously associated with a
healthy gut microbial composition when compared with
subjects with gastro-intestinal diseases44. Though not all of
these genera are classified in function, these four genera, as
well as Butyricimonas, are known to plant fiber degraders
and produce short-chain fatty acid (SCFAs)45–48. SCFAs
perform a pivotal role in the GBA49, besides being a
nutrient source for resident bacteria50. SCFAs beneficially
affect the immune system, e.g., by the secretion of cyto-
kines and T cell differentiation. Moreover, they protect
intestinally and blood–brain barrier permeability and
modulate the HPA axis through the vagal nerve50–54.
Increased SCFA production may hence contribute to the
protecting effect of probiotics on gut and brain health.
While we find an association between stress-related cog-
nitive performance and gut microbial abundance, none of
the physiological stress measures associated with the gut
microbial changes, which is in line with our previous
findings that these stress measures were not affected by
probiotics across the group24. The stress paradigm did
activate the HPA axis as measured by blood pressure,
heart rate, and cortisol24. Dampened cortisol responses
after probiotics’ use is not consistently observed in human
RCTs: while Messaoudi et al.14 found lowered urinary
levels of cortisol, Takada et al.19 only found lowered levels
when pooling salivary cortisol measures from three trials,
and Mohammadi et al.55 did not observe serum cortisol
changes due to probiotics even though well-being was
improved. The absence of physiological effects of the
probiotics in the current trial suggests there are other
Fig. 4 Association between the intervention-induced change in the relative abundance of genus Ruminococcaceae_UCG-003 and
intervention-induced protection of stress-induced working memory changes. Subjects with a higher increase in Ruminococcaceae_UCG-003
abundance after probiotics (right side of the x-axis) were also more protected from negative effects of stress on working memory after probiotics
(upper side of the y-axis).
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pathways involved rather than HPA (de-)activation. For
instance, the probiotics’ intervention could have resulted
in the prevention of stress-induced immune activation that
is known to affect brain neurotransmitters, e.g., catecho-
lamines, underlying cognitive performance56. In favor of
such a potential pathway are results using the current
multi-species probiotics mixture in rats, where the gut
metabolite indolepropionic acid was increased16. Indole-
propionic acid is known to improve intestinal barrier
function and to limit neuro-inflammation57. Moreover, in
the paper by Lin et al. Ruminococcaceae_UCG-003 abun-
dance associated negatively with the inflammatory bio-
marker C-reactive protein43. SCFAs can also contribute to
the reduction of stress-induced inflammation58,59. As we
did not directly measure gut metabolites in stool or serum,
nor inflammatory cytokines, we suggest future studies may
look into these functional pathways of how probiotics
support cognitive resilience to stress. We were not able to
determine if the bacterial strains included in the ‘Ecolo-
gic®Barrier‘ probiotic product changed after our inter-
vention. The 16S rRNA sequencing technique allows
robust and consistent identification of taxa up to the genus
category but not lower taxa (i.e., species). None of the
genera that were increased by the intervention include any
of the supplemented strains. When revising the genera
including the strains present in the probiotics mixture, we
observed a non-significant increase in relative abundance:
genus Bifidobactium increased 1,1% post-probiotics versus
pre–probiotics, and genus Lactobacillus increased 0.5%.
The genus Lactococcus was not detected in the sample. It
is important to note that the efficacy of probiotics does not
depend on and is not expected to be limited to the colo-
nization of the supplemented strains themselves. Probio-
tics can alter the relative abundance of multiple bacterial
groups, but also affect community dynamics in several
ways, e.g., through changes in pH, by outcompeting bac-
teria by utilizing nutrients, by promoting the growth of
resident bacteria through nutrient production, or by
occupying adherence sites on the intestinal wall50. In fact,
changes in gut microbial composition are not consistently
found following probiotics’ use50. Our findings of
probiotic-induced changes in other genera than supple-
mented, therefore, contribute to the understanding of
probiotics’ supplementation in healthy human subjects.
Our current findings are in need of replication, ideally in a
larger sample and extending the findings to a male sample.
Moreover, FFQ data as used in this study, only roughly
matches fiber intake, with a slight underestimation as
calculated in some studies60,61. The currently used short
FFQ (15min) was selected to control for large differences
in adherence to the Dutch healthy diet guidelines and to
obtain an estimate of fiber intake in order to control for
this potential confounder. The FFQ values should in no
way be interpreted quantitatively. Future studies that are
interested in actual interactions between diet and pro-
biotics supplementation should go for more extensive
measures like 24 h recalls or food diaries. Nevertheless,
another study similarly found variation in abundance of a
Ruminococcaceae genus to be associated with neuro-
cognitive measures: Bagga et al.62 tested, without a stress
paradigm, the neuro-cognitive effects of similar probiotics
product in healthy volunteers. They observed that irre-
spective of intervention, the OTU Ruminococca-
ceae_UCG_002 was negatively correlated with depressive
feelings. Even though this finding does not involve
Ruminococcaceae_UCG-003 specifically, the mentioned
genus belongs to the Ruminococcaceae family, meaning
they are evolutionary similar. With research into the
microbiota-GBA accumulating, it is interesting to see
whether the beneficial role of Ruminococcaceae genera in
neuro-cognitive performance in health and disease is
confirmed. Similar to our results, Bagga et al.62 also found
that memory performance was improved by the probiotics
supplementation, which was in their study associated with
changes in the Bacteroides genera. This difference in the
association between the studies, i.e., the currently observed
Ruminococcaceae_UCG-003 versus Bacteriodes, might not
be surprising given the different type of memory (working
memory versus emotional memory), different type of
probiotic product (Ecologic®Barrier versus Ecolo-
gic®825), and different sample (larger n= 56 instead of
n= 23 for microbiota analyses] and more homogenous
[only female] in our study). Another study investigated the
effect of probiotics in exam-related stress in healthy adults
(students)20. In this study, they used a single strain
(Lactobacillus casei strain Shirota YIT 9029, 1.0 × 1011
CFU per 100-ml bottle, 8 weeks supplementation; not
overlapping with any in this study). The authors found the
preservation of within-group diversity after probiotics
compared with placebo, whereas in our study between-
group diversity shifted in the probiotics group, and
increased abundance of several genera was observed (on
an uncorrected threshold). This difference in functional
effects likely partly arises due to the different primer
regions of the 16S rRNA gene studied; V1-2 in20 and V4 in
our study. These differences in study design (e.g., duration,
dose), probiotics product used (e.g., single-strain or multi-
strain), gut microbiome analysis techniques (e.g., in 16S
rRNA primer amplicon, DNA extraction method) hamper
comparability between probiotics’ studies. Formal repli-
cation studies are needed to overcome this limitation to
the probiotics field. Accumulation of probiotic trials in the
microbiota-GBA field will increase knowledge on the
effects, potentially by backtracking shared functional
effects (on gut microbial composition, physiology, or
behavior) to shared properties across these strains. Lastly,
significant effects of probiotics on the global beta diversity
measure were not observed in the current dataset.
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Variation in the gut microbial composition of healthy
adults is a natural biological phenomenon, as well as
technical variations e.g., due to sampling63. Interaction
effects can only appear when an intervention effect is
strong enough to supersede the natural temporal fluc-
tuations in the community, which, given our results,
seems not to be the case for the current probiotics
intervention in this healthy adult sample. It is important
to be aware that the community analyses, in this case,
beta diversity, are not a pre-requisite for assessing
changes in composition at (genus) taxonomy level64.
They are separate approaches each assessing different
aspects of the microbiome composition: beta diversity
values are extracted from the distribution of OTU’s,
which is a different distribution than the taxonomic data.
While it is of course true that the taxonomic char-
acterization depends on the OTU distribution, taxo-
nomic groups at the genus level are assigned based on
sequence similarity, creating a different metric. The lack
of global differences such as beta diversity does not
preclude individual taxonomic differences at the genus
level. In fact, relevant and significant intervention effects
at the taxonomic level may drown in community analysis
due to the nature of this global measure: a global ten-
dency across all taxa.
In conclusion, 4-weeks supplementation of probiotics
did not significantly increase the relative abundance of
the gut microbiota at genus level versus placebo. How-
ever, a group of eight genera showed an increase
(uncorrected) after probiotics compared to placebo. The
increased relative abundance of the gut bacterial genus
Ruminococcaccae_UCG-003 correlated significantly with
the positive effects of probiotics on stress-induced
working memory changes. In addition to our previous
findings of probiotics supporting cognitive performance
under stress relative to placebo24, our current exploratory
results suggest that these beneficial effects may be related
to changes in the gut microbiota community. More
research into the functional effects of gut microbial
changes would add to the understanding of probiotics’
modulation of the gut–brain axis.
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